数据链接：
官方服务：
资源简介：
Aetiology of BUD and first treatment options.
应用场景：
创建时间：
2015-12-02
相关数据集
Drug delivery systems based on micelles and gels of poloxamines and miltefosine-cyclodextrin complexes for the treatment of leishmaniasis
Leishmaniasis is a neglected tropical disease with high morbidity and mortality, considered the second leading cause of death worldwide by a parasitic agent after malaria. The available drugs against
DataCite Commons2025-07-09 更新70
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
BackgroundAlternative treatments for visceral leishmaniasis (VL) are required in East Africa. Paromomycin sulphate (PM) has been shown to be efficacious for VL treatment in India. MethodsA multi-centr
Figshare2016-01-19 更新20
Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia
Background High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in India and Nepal followed up for twelve months. Objective To identify epidemiological and clinical ri
NIAID Data Ecosystem20
Interview Guide for RBC
Interview questions addressed to the RBC Head of NTDs to find out the existing and future treatment interventions for patients affected by podoconiosis in Rwanda
Figshare2021-11-23 更新60
Baseline characteristics of VL-HIV co-infected adults treated with SSG, Gondar, Ethiopia (2010-2012, N = 57).
ART: combination antiretroviral treatment; IQR: interquartile range; VL: visceral leishmaniasis; a in 2 it was not documented
NIAID Data Ecosystem20
